Lazard Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30
| Closed | – | – | 2531 |
|
|
2024
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 2491 |
|
|
2024
Q3 | $0 | Sell |
30
-48
| -62% | – | ﹤0.01% | 2423 |
|
|
2024
Q2 | $1K | Sell |
78
-1,076
| -93% | -$13.8K | ﹤0.01% | 2173 |
|
|
2024
Q1 | $30K | Sell |
1,154
-640
| -36% | -$16.6K | ﹤0.01% | 1805 |
|
|
2023
Q4 | $52K | Buy |
1,794
+72
| +4% | +$2.09K | ﹤0.01% | 1880 |
|
|
2023
Q3 | $34K | Buy |
1,722
+79
| +5% | +$1.56K | ﹤0.01% | 1970 |
|
|
2023
Q2 | $32K | Buy |
1,643
+45
| +3% | +$876 | ﹤0.01% | 1971 |
|
|
2023
Q1 | $26K | Buy |
1,598
+320
| +25% | +$5.21K | ﹤0.01% | 1991 |
|
|
2022
Q4 | $24K | Sell |
1,278
-360
| -22% | -$6.76K | ﹤0.01% | 2104 |
|
|
2022
Q3 | $25K | Buy |
1,638
+5
| +0.3% | +$76 | ﹤0.01% | 2032 |
|
|
2022
Q2 | $21K | Buy |
1,633
+67
| +4% | +$862 | ﹤0.01% | 2124 |
|
|
2022
Q1 | $24K | Buy |
1,566
+430
| +38% | +$6.59K | ﹤0.01% | 2029 |
|
|
2021
Q4 | $24K | Buy |
1,136
+195
| +21% | +$4.12K | ﹤0.01% | 2015 |
|
|
2021
Q3 | $27K | Sell |
941
-463
| -33% | -$13.3K | ﹤0.01% | 1933 |
|
|
2021
Q2 | $61K | Buy |
1,404
+1,354
| +2,708% | +$58.8K | ﹤0.01% | 1515 |
|
|
2021
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 1811 |
|
|
2020
Q4 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1810 |
|
|
2018
Q4 | – | Sell |
-69,681
| Closed | -$1.72M | – | 1073 |
|
|
2018
Q3 | $1.72M | Buy |
+69,681
| New | +$1.72M | ﹤0.01% | 677 |
|